MYL-1402O
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MYL-1402O, covering 2021-02-01 to 2021-02-01. Get the full timeline:
Most recent: Clinical Trial Update: MYL-1402O Compared With Avastin®, in Patients With Stage IV nsNSCLC [Phase 3]